Osaic Holdings’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49K Sell
210
-716
-77% -$5.12K ﹤0.01% 7361
2026
Q1
$6.19K Hold
926
﹤0.01% 6571
2025
Q4
$5.05K Buy
926
+673
+266% +$4K ﹤0.01% 6698
2025
Q3
$1.56K Sell
253
-10
-4% -$65 ﹤0.01% 7214
2025
Q2
$1.65K Buy
+263
New +$1.54K ﹤0.01% 6998
2025
Q1
Sell
-3,740
Closed -$30.7K 7448
2024
Q4
$30.7K Sell
3,740
-5
-0.1% -$47 ﹤0.01% 5054
2024
Q3
$33.4K Buy
3,745
+232
+7% +$1.99K ﹤0.01% 5036
2024
Q2
$26.6K Buy
+3,513
New +$25.7K ﹤0.01% 5144

Other funds holding AURA

Osaic Holdings's AURA Position: Q2 2026 in Review

Osaic Holdings reduced its Aura Biosciences (AURA) stake by 77% in Q2 2026, selling an estimated $5.12K and leaving 210 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #7361.

Osaic Holdings first reported a position in AURA in Q2 2024 and has held it in 8 quarters since. The position peaked at $33.4K in Q3 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Osaic Holdings held 210 shares of Aura Biosciences worth $1.49K as of Q2 2026.
  • Osaic Holdings sold 716 Aura Biosciences shares in Q2 2026, an estimated $5.12K.
  • Aura Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7361 holding.
  • Osaic Holdings first reported a position in Aura Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Aura Biosciences position peaked at $33.4K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.